Literature DB >> 29443120

Differing trends in the incidence of vascular comorbidity in MS and the general population.

Amin Zarghami1.   

Abstract

Year:  2016        PMID： 29443120      PMCID： PMC5727712          DOI： 10.1212/01.CPJ.0000484746.05083.2d

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


× No keyword cloud information.
  6 in total

1.  Glucocorticoid use and serum lipid levels in US adults: the Third National Health and Nutrition Examination Survey.

Authors:  Hyon K Choi; John D Seeger
Journal:  Arthritis Rheum       Date:  2005-08-15

2.  Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis--an observational study.

Authors:  Paulus S Rommer; Karoline Buckow; David Ellenberger; Tim Friede; Dorothea Pitschnau-Michel; Jan Fuge; Olaf Stüve; Uwe K Zettl
Journal:  Eur J Clin Invest       Date:  2015-05-09       Impact factor: 4.686

Review 3.  Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events.

Authors:  Laurence Fardet; Bruno Fève
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

4.  Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort.

Authors:  M Cossburn; A A Pace; J Jones; R Ali; G Ingram; K Baker; C Hirst; J Zajicek; N Scolding; M Boggild; T Pickersgill; Y Ben-Shlomo; A Coles; N P Robertson
Journal:  Neurology       Date:  2011-07-27       Impact factor: 9.910

5.  Differing trends in the incidence of vascular comorbidity in MS and the general population.

Authors:  Ruth Ann Marrie; John Fisk; Helen Tremlett; Christina Wolfson; Sharon Warren; James Blanchard; Scott B Patten
Journal:  Neurol Clin Pract       Date:  2016-04

6.  A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy.

Authors:  Dora Liu; Alexandra Ahmet; Leanne Ward; Preetha Krishnamoorthy; Efrem D Mandelcorn; Richard Leigh; Jacques P Brown; Albert Cohen; Harold Kim
Journal:  Allergy Asthma Clin Immunol       Date:  2013-08-15       Impact factor: 3.406
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.